Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Hoffman Stephen J, Director. Officer active across 3 companies, notably Dicerna Pharmaceuticals Inc. In total, 8 reports have been published. Activity tracked since 17 June 2021. The latest transaction was disclosed on 23 October 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Stephen J. Hoffman is a Board Member at Dicerna Pharmaceuticals Inc and AcelRx Pharmaceuticals Inc. He brings his expertise in governance and strategy, actively participating in the direction of both companies.